Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02FEF
|
||||
| Former ID |
DNC008210
|
||||
| Drug Name |
4-(3-methoxy-benzylideneamino)-benzenesulfonamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529203] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C14H14N2O3S
|
||||
| Canonical SMILES |
COC1=CC=CC(=C1)C=NC2=CC=C(C=C2)S(=O)(=O)N
|
||||
| InChI |
1S/C14H14N2O3S/c1-19-13-4-2-3-11(9-13)10-16-12-5-7-14(8-6-12)20(15,17)18/h2-10H,1H3,(H2,15,17,18)
|
||||
| InChIKey |
PMXSUWQVMRZMRV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [529203] | |
| KEGG Pathway | Arachidonic acid metabolism | ||||
| Metabolic pathways | |||||
| NF-kappa B signaling pathway | |||||
| VEGF signaling pathway | |||||
| TNF signaling pathway | |||||
| Retrograde endocannabinoid signaling | |||||
| Serotonergic synapse | |||||
| Ovarian steroidogenesis | |||||
| Oxytocin signaling pathway | |||||
| Regulation of lipolysis in adipocytes | |||||
| Leishmaniasis | |||||
| Pathways in cancer | |||||
| Chemical carcinogenesis | |||||
| MicroRNAs in cancer | |||||
| Small cell lung cancer | |||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.